🇺🇸 FDA
Pipeline program

PENNVAX-GP

DAIDS-ES 38409

Phase 2 mab completed

Quick answer

PENNVAX-GP for HIV-1-infection is a Phase 2 program (mab) at INOVIO PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
INOVIO PHARMACEUTICALS, INC.
Indication
HIV-1-infection
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials